PR Newswire Asia's news

 < Previous page   |   Title only   |   Print    Next page > 
     
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy ...
2026-06-17T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Diplomats, business leaders discuss global cooperation at Beijing CBD forum
BEIJING , June 17, 2026 /PRNewswire/ -- This is a report from China.org.cn ...
2026-06-17T    Banking/Financial Service   Computer/Electronics   Publishing/Information Service 
FinVolution Group Publishes Eighth Annual ESG Report
SHANGHAI , June 17, 2026 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading  fintech platform operating across China and overseas markets, ...
2026-06-17T    Banking/Financial Service   Computer/Electronics 
Yiren Digital to Report First Quarter 2026 Financial Results on June 25, 2026
BEIJING , June 17, 2026 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), a leading fintech company specializing in digital consumer lending, insurance ...
2026-06-17T    Banking/Financial Service   Computer/Electronics 
Bybit Rewards Responsible AI Adoption with 30,000 USDT in Prizes for AI Subaccount Users
DUBAI, UAE , June 17, 2026 /PRNewswire/ -- Bybit , the world's second-largest cryptocurrency exchange by trading volume, is unveiling a new 30,000 USDT prize pool to encourage safe AI agent integration. ...
2026-06-17T    Banking/Financial Service   Computer/Electronics 
83% of CEE suppliers affected by late payments, Atradius survey reveals
AMSTERDAM , June 17, 2026 /PRNewswire/ -- Central and Eastern European companies continue to balance cash and credit, with 54% of B2B sales paid at the point of sale and 46% made on credit. Yet the credit ...
2026-06-17T    Banking/Financial Service   Publishing/Information Service 
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat
STOCKHOLM , June 17, 2026 /PRNewswire/ -- Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic inflammatory diseases, today announced that 50% of the target of 190 ...
2026-06-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
NX China to Exhibit at 4th China International Supply Chain Expo (CISCE)
TOKYO , June 17, 2026 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., will participate in the 4th China International ...
2026-06-17T    Transportation   Trade show news 
Clarivate Releases Journal Citation Reports 2026
Advancing transparency and responsible journal evaluation ...
2026-06-17T    Computer/Electronics   Education   Publishing/Information Service 
Higher, Faster, Lighter: Fox ESS Unveils a Next-Level Brand Experience at Intersolar Europe 2026
MUNICH , June 17, 2026 /PRNewswire/ -- Fox ESS is set to make a bold impact at Intersolar Europe 2026 with an expanded exhibition presence at Booth B1. 210, offering over 300㎡ of ...
2026-06-17T    Environmental Products & Services   Green Technology   Oil/Energy 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.